Juvenile Idiopathic Arthritis: New Insights into Classification, Measures of Outcome, and Pharmacotherapy

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.13, Iss.3, 2011-06, pp. : 161-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives

By Wahezi Dawn M Ilowite Norman T

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 975-989

Informa Healthcare

Access to resources Recommend Favorite

Treatment strategies for juvenile idiopathic arthritis

By Klein Ariane Horneff Gerd

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 18, 2009-12 ,pp. : 3049-3060

Informa Healthcare

Access to resources Recommend Favorite

Atopy in children with systemic onset juvenile idiopathic arthritis (SoJIA) is associated with a worse outcome

By Zhang Wen-Ming Xu Ling-Yun Lu Yan-ming Cao Lan-Fang

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 176-181

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis)

By Agle Lucila MA Rosenkranz Margalit Lehman Thomas JA

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 1, 2003-01 ,pp. : 19-28

Informa Healthcare

Access to resources Recommend Favorite

Tocilizumab takes control of juvenile idiopathic arthritis

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite